CD8A and neoplasm: Additionally, higher ratios of CD8+ to forkhead box protein 3+ tumor infiltrating lymphocytes were detected in non-pCR TNBC patients with lower residual cancer burden (RCB) after NAC, representing that anti-tumor immune response was related with the response to NAC (11).